Difficulty: Medium
Average Score: 66%
Practice
Indicate a selective inhibitor of monoamine oxidase B:
Correct answer
D
Rationale
In the context of safety pharmacology across the lifespan, understanding the mechanism of action and selectivity of drugs is crucial. In this question, the correct answer is D) Selegiline, a selective inhibitor of monoamine oxidase B (MAO-B). Selegiline specifically targets MAO-B, an enzyme responsible for the breakdown of dopamine in the brain. By inhibiting MAO-B, selegiline increases dopamine levels, making it a valuable treatment for conditions like Parkinson's disease.
Now, let's analyze why the other options are incorrect:
A) Levodopa: Levodopa is a precursor to dopamine and is converted to dopamine in the brain. It is not a selective inhibitor of MAO-B.
B) Amantadine: Amantadine is an antiviral medication that also has dopaminergic effects, but it does not selectively inhibit MAO-B.
C) Tolcapone: Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor, not a selective MAO-B inhibitor.
Educational context:
Understanding the selectivity of pharmacological agents is essential to ensure safe and effective treatment, especially when considering safety across different age groups. In the case of MAO-B inhibitors, their selectivity determines their side effect profile and potential interactions with other medications. This knowledge is vital for healthcare professionals working with patients of all ages to provide optimal care while minimizing risks and adverse effects.
Now, let's analyze why the other options are incorrect:
A) Levodopa: Levodopa is a precursor to dopamine and is converted to dopamine in the brain. It is not a selective inhibitor of MAO-B.
B) Amantadine: Amantadine is an antiviral medication that also has dopaminergic effects, but it does not selectively inhibit MAO-B.
C) Tolcapone: Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor, not a selective MAO-B inhibitor.
Educational context:
Understanding the selectivity of pharmacological agents is essential to ensure safe and effective treatment, especially when considering safety across different age groups. In the case of MAO-B inhibitors, their selectivity determines their side effect profile and potential interactions with other medications. This knowledge is vital for healthcare professionals working with patients of all ages to provide optimal care while minimizing risks and adverse effects.